Comparison of the cytokines levels in aqueous humor in vitrectomized eyes versus non-vitrectomized eyes with diabetic macular edema

Glassman AR, Wells JA 3rd, Josic K, Maguire MG, Antoszyk AN, Baker C, Beaulieu WT, Elman MJ, Jampol LM, Sun JK (2020) Five-year outcomes after initial aflibercept, bevacizumab, or ranibizumab treatment for diabetic macular edema (Protocol T Extension Study). Ophthalmology 127:1201–1210

Article  PubMed  Google Scholar 

Liu K, Wang H, He W, Ye J, Song Y, Wang Y, Liu X, Wu Z, Chen S, Fan K et al (2022) Intravitreal conbercept for diabetic macular oedema: 2-year results from a randomised controlled trial and open-label extension study. Br J Ophthalmol 106:1436–1443

Article  PubMed  Google Scholar 

Yoshida S, Kubo Y, Kobayashi Y, Zhou Y, Nakama T, Yamaguchi M, Tachibana T, Ishikawa K, Arita R, Nakao S et al (2015) Increased vitreous concentrations of MCP-1 and IL-6 after vitrectomy in patients with proliferative diabetic retinopathy: Possible association with postoperative macular oedema. Br J Ophthalmol 99:960–966

Article  PubMed  Google Scholar 

Yanyali A, Aytug B, Horozoglu F, Nohutcu AF (2007) Bevacizumab (Avastin) for diabetic macular edema in previously vitrectomized eyes. Am J Ophthalmol 144:124–126

Article  CAS  PubMed  Google Scholar 

Koyanagi Y, Yoshida S, Kobayashi Y, Kubo Y, Yamaguchi M, Nakama T, Nakao S, Ikeda Y, Ohshima Y, Ishibashi T et al (2016) Comparison of the effectiveness of intravitreal ranibizumab for diabetic macular edema in vitrectomized and nonvitrectomized eyes. Ophthalmologica 236:67–73

Article  PubMed  Google Scholar 

Chen YY, Chen PY, Chen FT, Chen YJ, Wang JK (2018) Comparison of efficacy of intravitreal ranibizumab between non-vitrectomized and vitrectomized eyes with diabetic macular edema. Int Ophthalmol 38:293–299

PubMed  Google Scholar 

Funatsu H, Yamashita H, Noma H, Mimura T, Nakamura S, Sakata K, Hori S (2005) Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients. Graefe’s Arch Clin Exp Ophthalmol 243:3–8

Article  CAS  Google Scholar 

Lee SS, Ghosn C, Yu Z, Zacharias LC, Kao H, Lanni C, Abdelfattah N, Kuppermann B, Csaky KG, D’Argenio DZ et al (2010) Vitreous VEGF clearance is increased after vitrectomy. Investig Ophthalmol Vis Sci 51:2135–2138

Article  Google Scholar 

Niwa Y, Kakinoki M, Sawada T, Wang X, Ohji M (2015) Ranibizumab and aflibercept: intraocular pharmacokinetics and their effects on aqueous VEGF level in vitrectomized and nonvitrectomized macaque eyes. Investig Ophthalmol Vis Sci 56:6501–6505

Article  CAS  Google Scholar 

Kakinoki M, Sawada O, Sawada T, Saishin Y, Kawamura H, Ohji M (2012) Effect of vitrectomy on aqueous VEGF concentration and pharmacokinetics of bevacizumab in macaque monkeys. Investig Ophthalmol Vis Sci 53:5877–5880

Article  CAS  Google Scholar 

Dvorak HF, Brown LF, Detmar M, Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029–1039

CAS  PubMed  PubMed Central  Google Scholar 

Miyamoto K, Khosrof S, Bursell SE, Moromizato Y, Aiello LP, Ogura Y, Adamis AP (2000) Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1). Am J Pathol 156:1733–1739

Article  CAS  PubMed  PubMed Central  Google Scholar 

De Falco S, Gigante B, Persico MG (2002) Structure and function of placental growth factor. Trends Cardiovasc Med 12:241–246

Article  PubMed  Google Scholar 

DiSalvo J, Bayne ML, Conn G, Kwok PW, Trivedi PG, Soderman DD, Palisi TM, Sullivan KA, Thomas KA (1995) Purification and characterization of a naturally occurring vascular endothelial growth factor·placenta growth factor heterodimer. J Biol Chem 270:7717–7723

Article  CAS  PubMed  Google Scholar 

Noma H, Mimura T, Yasuda K, Motohashi R, Kotake O, Shimura M (2017) Aqueous humor levels of soluble vascular endothelial growth factor receptor and inflammatory factors in diabetic macular edema. Ophthalmologica 238:81–88

Article  CAS  PubMed  Google Scholar 

Bressler SB, Melia M, Glassman AR, Almukhtar T, Jampol LM, Shami M, Berger BB, Bressler NM (2015) Ranibizumab plus prompt or deferred laser for diabetic macular edema in eyes with vitrectomy before anti-vascular endothelial growth factor therapy. Retina 35(12):2516–2528

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn E (2004) Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 56:549–580

Article  CAS  PubMed  Google Scholar 

Ferrara N, Gerber HP, LeCouter J (1995) The biology of VEGF and its receptors. Nat Med 9:669–676

Article  Google Scholar 

Wang H, Lafdil F, Kong X, Gao B (2011) Signal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target. Int J Biol Sci 7:536–550

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ebihara N, Matsuda A, Nakamura S, Matsuda H, Murakami A (2011) Role of the IL-6 classic-and trans-signaling pathways in corneal sterile inflammation and wound healing. Investig Ophthalmol Vis Sci 52:8549–8557

Article  CAS  Google Scholar 

Funatsu H, Yamashita H, Ikeda T, Mimura T, Eguchi S, Hori S (2003) Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema. Ophthalmology 110:1690–1696

Article  PubMed  Google Scholar 

Roh MI, Kim HS, Song JH, Lim JB, Kwon OW (2009) Effect of intravitreal bevacizumab injection on aqueous humor cytokine levels in clinically significant macular edema. Ophthalmology 116:80–86

Article  PubMed  Google Scholar 

Jo N, Wu GS, Rao NA (2003) Upregulation of chemokine expression in the retinal vasculature in ischemia-reperfusion injury. Investig Ophthalmol Vis Sci 44:4054–4060

Article  Google Scholar 

Funk M, Schmidinger G, Maar N, Bolz M, Benesch T, Zlabinger GJ, Schmidt-Erfurth UM (2010) Angiogenic and inflammatory markers in the intraocular fluid of eyes with diabetic macular edema and influence of therapy with bevacizumab. Retina 30:1412–1419

Article  PubMed  Google Scholar 

Ide N, Hirase T, Nishimoto-Hazuku A, Ikeda Y, Node K (2008) Angiotensin II increases expression of IP-10 and the renin-angiotensin system in endothelial cells. Hypertens Res 31:1257–1267

Article  CAS  PubMed  Google Scholar 

Yoshimura T (2018) The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally? Cell Mol Immunol 15:335–345

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hong KH, Ryu J, Han KH (2005) Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A. Blood 105:1405–1407

Article  CAS  PubMed  Google Scholar 

Gu R, Zhou M, Jiang C, Yu J, Xu G (2016) Elevated concentration of cytokines in aqueous in post-vitrectomy eyes. Clin Exp Ophthalmol 44:128–134

Article  PubMed  Google Scholar 

Park YG, Jee D, Kwon J (2019) Aqueous humor cytokine levels in diabetic macular edema patients with cotton-wool spots. J Diabetes Res 2019:1–9

Article  CAS  Google Scholar 

Tang J, Kern TS (2011) Inflammation in diabetic retinopathy. Prog Retin Eye Res 30:343–358

Article  CAS  PubMed  PubMed Central  Google Scholar 

Joussen AM, Poulaki V, Qin W, Kirchhof B, Mitsiades N, Wiegand SJ, Rudge J, Yancopoulos GD, Adamis AP (2002) Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. Am J Pathol 160:501–509

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hillier RJ, Ojaimi E, Wong DT, Mak MY, Berger AR, Kohly RP, Kertes PJ, Forooghian F, Boyd SR, Eng K et al (2017) Aqueous humor cytokine levels as biomarkers of disease severity in diabetic macular edema. Retina 37:761–769

Article  CAS  PubMed  Google Scholar 

Oh IK, Kim SW, Oh J, Lee TS, Huh K (2010) Inflammatory and angiogenic factors in the aqueous humor and the relationship to diabetic retinopathy. Curr Eye Res 35:1116–1127

Article  CAS  PubMed  Google Scholar 

留言 (0)

沒有登入
gif